Fluorometric detection of protein-ligand engagement: The case of phosphodiesterase5
Open Access
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 149, 335-342
Abstract
No abstract availableKeywords
Funding Information
- MIUR, Ministero dell'Istruzione, dell'Università e della Ricerca
- Fondo di Ateneo per la Ricerca
This publication has 25 references indexed in Scilit:
- Synthesis, Biological Evaluation, and Docking Studies of Tetrahydrofuran- Cyclopentanone- and Cyclopentanol-Based Ligands Acting at Adrenergic α1- and Serotonine 5-HT1AReceptorsJournal of Medicinal Chemistry, 2011
- In-gel digestion for mass spectrometric characterization of proteins and proteomesNature Protocols, 2006
- Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical UsePharmacological Reviews, 2006
- Improved Photostable FRET-Competent Biarsenical−Tetracysteine Probes Based on Fluorinated FluoresceinsJournal of the American Chemical Society, 2006
- A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cellsNature Methods, 2005
- Binding of Tritiated Sildenafil, Tadalafil, or Vardenafil to the Phosphodiesterase-5 Catalytic Site Displays Potency, Specificity, Heterogeneity, and cGMP StimulationMolecular Pharmacology, 2004
- Structure of the catalytic domain of human phosphodiesterase 5 with bound drug moleculesNature, 2003
- New Biarsenical Ligands and Tetracysteine Motifs for Protein Labeling in Vitro and in Vivo: Synthesis and Biological ApplicationsJournal of the American Chemical Society, 2002
- Specific Covalent Labeling of Recombinant Protein Molecules Inside Live CellsScience, 1998
- An exact mathematical expression for describing competitive binding of two different ligands to a protein moleculeFEBS Letters, 1995